Friday, January 25th, 2008
Judah Folkman's Legacy
Medical researcher Judah Folkman passed away last week at the age of 74. Until his death, he was Director of the Vascular Biology Program at Children's Hospital Boston. A central theme of his research was the idea of angiogenesis, the formation of new blood vessels. In 1971, Folkman published a paper in the New England Journal of Medicine arguing that angiogenesis was a key component in the growth of tumors. If a way could be found to limit the growth of blood vessels servicing a tumor, he reasoned, the tumor would be unable to grow. The idea has been incorporated into many differnt fields, and has led to the development of drugs such as Avastin (Bevacizumab), an angiogenisis inhibitor developed by Genentech. In this segment, we'll talk about Folkman's work and scientific legacy.
Guests
Robert Cooke
Science Writer
Author, "Dr. Folkman's War: Angiogenesis and the Struggle to Defeat Cancer,"
(Random House, 2001)
Stow, Massachusetts
Larry Norton
Deputy-in-Chief of Breast
Cancer Programs
Memorial Sloan-Kettering Cancer Center
New York, New York
Related Links
- Children's Hospital: Remebering Judah Folkman
- Boston Globe: The revolutionary doctor
- NPR:Folkman, Cancer Research Pioneer, Dies at 74
- National Cancer Institute: Angiogenesis
- Genentech: Research: Angiogenesis
Segment produced by:Annette Heist
Listen:
Friday, January 25th, 2008
Elsewhere on Sciencefriday.com
Tobacco Plants Grow Cancer Vaccines
Genetic Marker for Breast Cancer
A Window into the Heart ... and Everything Else Fountain of Youth for Yeast Towards a Saliva Test for Cancers?
Cancer Update with Robert Weinberg
SciFri File: Genetic Testing for Breast and Ovarian Cancer Sunny Delight










